SIX1 Downregulation Suppresses Self-renewal Capacity and THY1 Expression in Hepatocellular Carcinoma and SIX1 Dominate the Survival in Liver Cancer
| dc.contributor.author | Balcik-Ercin, Pelin | |
| dc.contributor.author | Aysan, Arzu | |
| dc.contributor.author | Salik, Nazli | |
| dc.contributor.author | Erciyas, Esma | |
| dc.date.accessioned | 2025-10-29T11:08:01Z | |
| dc.date.issued | 2023 | |
| dc.department | Fakülteler, Temel Bilimler Fakültesi, Moleküler Biyoloji ve Genetik Bölümü | |
| dc.description.abstract | Background/Aims: Sine oculis homeoprotein 1 exerts an essential role in embryonic development, and it was also identified to be reactivated in various types of mammalian cancer. The sine oculis homeoprotein 1 transcription factor was demonstrated to induce epithelial-mesenchymal transition, regulate crucial genes associated with cancer progression, and increase the oncogenic potential of cells. Therefore, the present study aimed to identify the role of sine oculis homeoprotein 1 in cancer. Materials and Methods: Sine oculis homeoprotein 1 gene expression was tested with real-time quantitative polymerase chain reaction (PCR) in different cancer types. Sine oculis homeoprotein 1 expression was suppressed by short hairpin RNA transduction in the SNU398 hepatocellular carcinoma cell line. The effects of sine oculis homeoprotein 1 on cell proliferation, drug resistance, and sphere formation were assessed in shSIX1 cells. Immunohistochemical and in silico analyses were performed to determine the prognostic role of sine oculis homeoprotein 1 expression. Results: The upregulated expression levels of sine oculis homeoprotein 1 were revealed to be correlated with the stage of the disease in breast, colon, and liver cancer, with liver cancer exhibiting the highest expression profile. Sine oculis homeoprotein 1 downregulation significantly affected cell proliferation and suppressed sorafenib resistance and sphere-forming ability. Furthermore, sine oculis homeoprotein 1 knockdown cells were identified to have decreased CD90 levels, essential for cancer stem cell properties. Finally, sine oculis homeoprotein 1 expression was a CD90-independent biomarker for the clinical prognosis of liver cancer. Conclusion: The results of this study showed that the knockdown of sine oculis homeoprotein 1 expression might help to prevent hepatocarcinogenesis by increasing drug sensitivity and controlling tumor sphere formation. Overall, these results indicated that sine oculis homeoprotein 1 expression might be useful as a diagnostic marker for patients with hepatocellular carcinoma. | |
| dc.identifier.doi | 10.5152/tjg.2023.22293 | |
| dc.identifier.endpage | 889 | |
| dc.identifier.issn | 2148-5607 | |
| dc.identifier.issue | 8 | |
| dc.identifier.orcid | 0000-0002-3470-0393 | |
| dc.identifier.orcid | 0000-0001-7217-3347 | |
| dc.identifier.pmid | 37427884 | |
| dc.identifier.scopus | 2-s2.0-85166442669 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 881 | |
| dc.identifier.trdizinid | 1241558 | |
| dc.identifier.uri | https://doi.org/10.5152/tjg.2023.22293 | |
| dc.identifier.uri | https://search.trdizin.gov.tr/tr/yayin/detay/1241558 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14854/5155 | |
| dc.identifier.volume | 34 | |
| dc.identifier.wos | WOS:001109157300012 | |
| dc.identifier.wosquality | Q4 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | TR-Dizin | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Aves | |
| dc.relation.ispartof | Turkish Journal of Gastroenterology | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WOS_20251020 | |
| dc.subject | SIX1 | |
| dc.subject | hepatocellular carcinoma | |
| dc.subject | drug response | |
| dc.subject | CD90 | |
| dc.subject | survival | |
| dc.title | SIX1 Downregulation Suppresses Self-renewal Capacity and THY1 Expression in Hepatocellular Carcinoma and SIX1 Dominate the Survival in Liver Cancer | |
| dc.type | Article |








